Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

ALK4/5-dependent TGF-β signaling contributes to the crosstalk between neurons and microglia following axonal lesion.

Raffo-Romero A, Arab T, Van Camp C, Lemaire Q, Wisztorski M, Franck J, Aboulouard S, Le Marrec-Croq F, Sautiere PE, Vizioli J, Salzet M, Lefebvre C.

Sci Rep. 2019 May 3;9(1):6896. doi: 10.1038/s41598-019-43328-x.

2.

Paclitaxel Treatment and Proprotein Convertase 1/3 (PC1/3) Knockdown in Macrophages is a Promising Antiglioma Strategy as Revealed by Proteomics and Cytotoxicity Studies.

Duhamel M, Rose M, Rodet F, Murgoci AN, Zografidou L, Régnier-Vigouroux A, Abeele FV, Kobeissy F, Nataf S, Pays L, Wisztorski M, Cizkova D, Fournier I, Salzet M.

Mol Cell Proteomics. 2018 Jun;17(6):1126-1143. doi: 10.1074/mcp.RA117.000443. Epub 2018 Mar 12.

3.

Spatially-Resolved Top-down Proteomics Bridged to MALDI MS Imaging Reveals the Molecular Physiome of Brain Regions.

Delcourt V, Franck J, Quanico J, Gimeno JP, Wisztorski M, Raffo-Romero A, Kobeissy F, Roucou X, Salzet M, Fournier I.

Mol Cell Proteomics. 2018 Feb;17(2):357-372. doi: 10.1074/mcp.M116.065755. Epub 2017 Nov 9.

4.

Combined Mass Spectrometry Imaging and Top-down Microproteomics Reveals Evidence of a Hidden Proteome in Ovarian Cancer.

Delcourt V, Franck J, Leblanc E, Narducci F, Robin YM, Gimeno JP, Quanico J, Wisztorski M, Kobeissy F, Jacques JF, Roucou X, Salzet M, Fournier I.

EBioMedicine. 2017 Jul;21:55-64. doi: 10.1016/j.ebiom.2017.06.001. Epub 2017 Jun 3.

5.

Droplet-Based Liquid Extraction for Spatially-Resolved Microproteomics Analysis of Tissue Sections.

Wisztorski M, Quanico J, Franck J, Fatou B, Salzet M, Fournier I.

Methods Mol Biol. 2017;1618:49-63. doi: 10.1007/978-1-4939-7051-3_6.

PMID:
28523499
6.

Combined MALDI Mass Spectrometry Imaging and Parafilm-Assisted Microdissection-Based LC-MS/MS Workflows in the Study of the Brain.

Quanico J, Franck J, Wisztorski M, Salzet M, Fournier I.

Methods Mol Biol. 2017;1598:269-283. doi: 10.1007/978-1-4939-6952-4_13.

PMID:
28508367
7.

Progress and Potential of Imaging Mass Spectrometry Applied to Biomarker Discovery.

Quanico J, Franck J, Wisztorski M, Salzet M, Fournier I.

Methods Mol Biol. 2017;1598:21-43. doi: 10.1007/978-1-4939-6952-4_2. Review.

PMID:
28508356
8.

Integrated mass spectrometry imaging and omics workflows on the same tissue section using grid-aided, parafilm-assisted microdissection.

Quanico J, Franck J, Wisztorski M, Salzet M, Fournier I.

Biochim Biophys Acta Gen Subj. 2017 Jul;1861(7):1702-1714. doi: 10.1016/j.bbagen.2017.03.006. Epub 2017 Mar 11.

PMID:
28300637
9.

Evaluation of non-supervised MALDI mass spectrometry imaging combined with microproteomics for glioma grade III classification.

Le Rhun E, Duhamel M, Wisztorski M, Gimeno JP, Zairi F, Escande F, Reyns N, Kobeissy F, Maurage CA, Salzet M, Fournier I.

Biochim Biophys Acta Proteins Proteom. 2017 Jul;1865(7):875-890. doi: 10.1016/j.bbapap.2016.11.012. Epub 2016 Nov 24.

PMID:
27890679
10.

NanoLC-MS coupling of liquid microjunction microextraction for on-tissue proteomic analysis.

Quanico J, Franck J, Cardon T, Leblanc E, Wisztorski M, Salzet M, Fournier I.

Biochim Biophys Acta Proteins Proteom. 2017 Jul;1865(7):891-900. doi: 10.1016/j.bbapap.2016.11.002. Epub 2016 Nov 9.

PMID:
27836619
11.

Proteomic Analysis of the Spatio-temporal Based Molecular Kinetics of Acute Spinal Cord Injury Identifies a Time- and Segment-specific Window for Effective Tissue Repair.

Devaux S, Cizkova D, Quanico J, Franck J, Nataf S, Pays L, Hauberg-Lotte L, Maass P, Kobarg JH, Kobeissy F, Mériaux C, Wisztorski M, Slovinska L, Blasko J, Cigankova V, Fournier I, Salzet M.

Mol Cell Proteomics. 2016 Aug;15(8):2641-70. doi: 10.1074/mcp.M115.057794. Epub 2016 Jun 1.

12.

In vivo Real-Time Mass Spectrometry for Guided Surgery Application.

Fatou B, Saudemont P, Leblanc E, Vinatier D, Mesdag V, Wisztorski M, Focsa C, Salzet M, Ziskind M, Fournier I.

Sci Rep. 2016 May 18;6:25919. doi: 10.1038/srep25919.

13.

Proprotein convertase 1/3 inhibited macrophages: A novel therapeutic based on drone macrophages.

Duhamel M, Rodet F, Murgoci A, Wisztorski M, Day R, Fournier I, Salzet M.

EuPA Open Proteom. 2016 Mar 5;11:20-22. doi: 10.1016/j.euprot.2016.03.003. eCollection 2016 Jun.

14.

Spatially-resolved protein surface microsampling from tissue sections using liquid extraction surface analysis.

Wisztorski M, Desmons A, Quanico J, Fatou B, Gimeno JP, Franck J, Salzet M, Fournier I.

Proteomics. 2016 Jun;16(11-12):1622-32. doi: 10.1002/pmic.201500508. Epub 2016 Apr 13.

PMID:
26929135
15.

The proprotein convertase PC1/3 regulates TLR9 trafficking and the associated signaling pathways.

Duhamel M, Rodet F, Murgoci AN, Desjardins R, Gagnon H, Wisztorski M, Fournier I, Day R, Salzet M.

Sci Rep. 2016 Jan 18;6:19360. doi: 10.1038/srep19360.

16.

Substrate-Mediated Laser Ablation under Ambient Conditions for Spatially-Resolved Tissue Proteomics.

Fatou B, Wisztorski M, Focsa C, Salzet M, Ziskind M, Fournier I.

Sci Rep. 2015 Dec 17;5:18135. doi: 10.1038/srep18135.

17.

Inter- and intra-organ spatial distributions of sea star saponins by MALDI imaging.

Demeyer M, Wisztorski M, Decroo C, De Winter J, Caulier G, Hennebert E, Eeckhaut I, Fournier I, Flammang P, Gerbaux P.

Anal Bioanal Chem. 2015 Nov;407(29):8813-24. doi: 10.1007/s00216-015-9044-0. Epub 2015 Sep 28.

PMID:
26412246
18.

Delivery of Alginate Scaffold Releasing Two Trophic Factors for Spinal Cord Injury Repair.

Grulova I, Slovinska L, Blaško J, Devaux S, Wisztorski M, Salzet M, Fournier I, Kryukov O, Cohen S, Cizkova D.

Sci Rep. 2015 Sep 8;5:13702. doi: 10.1038/srep13702.

19.

Molecular Consequences of Proprotein Convertase 1/3 (PC1/3) Inhibition in Macrophages for Application to Cancer Immunotherapy: A Proteomic Study.

Duhamel M, Rodet F, Delhem N, Vanden Abeele F, Kobeissy F, Nataf S, Pays L, Desjardins R, Gagnon H, Wisztorski M, Fournier I, Day R, Salzet M.

Mol Cell Proteomics. 2015 Nov;14(11):2857-77. doi: 10.1074/mcp.M115.052480. Epub 2015 Sep 1.

20.

MALDI-MS and NanoSIMS imaging techniques to study cnidarian-dinoflagellate symbioses.

Kopp C, Wisztorski M, Revel J, Mehiri M, Dani V, Capron L, Carette D, Fournier I, Massi L, Mouajjah D, Pagnotta S, Priouzeau F, Salzet M, Meibom A, Sabourault C.

Zoology (Jena). 2015 Apr;118(2):125-31. doi: 10.1016/j.zool.2014.06.006. Epub 2014 Oct 5.

PMID:
25447219
21.

Calreticulin contributes to C1q-dependent recruitment of microglia in the leech Hirudo medicinalis following a CNS injury.

Le Marrec-Croq F, Bocquet-Garcon A, Vizioli J, Vancamp C, Drago F, Franck J, Wisztorski M, Salzet M, Sautiere PE, Lefebvre C.

Med Sci Monit. 2014 Apr 19;20:644-53. doi: 10.12659/MSM.890091.

22.

On the origin of increased sensitivity and mass resolution using silicon masks in MALDI.

Diologent L, Franck J, Wisztorski M, Treizebre A, Focsa C, Fournier I, Ziskind M.

Anal Chem. 2014 Feb 4;86(3):1404-13. doi: 10.1021/ac401329r. Epub 2014 Jan 22.

PMID:
24422461
23.

Direct detection of alternative open reading frames translation products in human significantly expands the proteome.

Vanderperre B, Lucier JF, Bissonnette C, Motard J, Tremblay G, Vanderperre S, Wisztorski M, Salzet M, Boisvert FM, Roucou X.

PLoS One. 2013 Aug 12;8(8):e70698. doi: 10.1371/journal.pone.0070698. eCollection 2013.

24.

Quantification-based mass spectrometry imaging of proteins by parafilm assisted microdissection.

Franck J, Quanico J, Wisztorski M, Day R, Salzet M, Fournier I.

Anal Chem. 2013 Sep 3;85(17):8127-34. doi: 10.1021/ac4009397. Epub 2013 Aug 12.

PMID:
23869483
25.

Proteomic analyses of serous and endometrioid epithelial ovarian cancers - cases studies - molecular insights of a possible histological etiology of serous ovarian cancer.

Longuespée R, Gagnon H, Boyon C, Strupat K, Dauly C, Kerdraon O, Ighodaro A, Desmons A, Dupuis J, Wisztorski M, Vinatier D, Fournier I, Day R, Salzet M.

Proteomics Clin Appl. 2013 Jun;7(5-6):337-54. doi: 10.1002/prca.201200079.

26.

Microproteomics by liquid extraction surface analysis: application to FFPE tissue to study the fimbria region of tubo-ovarian cancer.

Wisztorski M, Fatou B, Franck J, Desmons A, Farré I, Leblanc E, Fournier I, Salzet M.

Proteomics Clin Appl. 2013 Apr;7(3-4):234-40. doi: 10.1002/prca.201200070. Epub 2013 Mar 6.

PMID:
23339084
27.

Development of liquid microjunction extraction strategy for improving protein identification from tissue sections.

Quanico J, Franck J, Dauly C, Strupat K, Dupuy J, Day R, Salzet M, Fournier I, Wisztorski M.

J Proteomics. 2013 Feb 21;79:200-18. doi: 10.1016/j.jprot.2012.11.025. Epub 2013 Jan 2.

PMID:
23291530
28.

A new safety concern for glaucoma treatment demonstrated by mass spectrometry imaging of benzalkonium chloride distribution in the eye, an experimental study in rabbits.

Brignole-Baudouin F, Desbenoit N, Hamm G, Liang H, Both JP, Brunelle A, Fournier I, Guerineau V, Legouffe R, Stauber J, Touboul D, Wisztorski M, Salzet M, Laprevote O, Baudouin C.

PLoS One. 2012;7(11):e50180. doi: 10.1371/journal.pone.0050180. Epub 2012 Nov 27. Erratum in: PLoS One. 2013;8(1). doi:10.1371/annotation/b97d3c0d-b49e-40e3-a6b4-5155bd9bf3c9.

29.

Targeted mass spectrometry imaging: specific targeting mass spectrometry imaging technologies from history to perspective.

Gagnon H, Franck J, Wisztorski M, Day R, Fournier I, Salzet M.

Prog Histochem Cytochem. 2012 Oct;47(3):133-74. doi: 10.1016/j.proghi.2012.08.002. Epub 2012 Sep 15. Review.

PMID:
22985794
30.

Ovarian cancer molecular pathology.

Longuespée R, Boyon C, Desmons A, Vinatier D, Leblanc E, Farré I, Wisztorski M, Ly K, D'Anjou F, Day R, Fournier I, Salzet M.

Cancer Metastasis Rev. 2012 Dec;31(3-4):713-32. doi: 10.1007/s10555-012-9383-7. Review.

31.

AMASS: algorithm for MSI analysis by semi-supervised segmentation.

Bruand J, Alexandrov T, Sistla S, Wisztorski M, Meriaux C, Becker M, Salzet M, Fournier I, Macagno E, Bafna V.

J Proteome Res. 2011 Oct 7;10(10):4734-43. doi: 10.1021/pr2005378. Epub 2011 Aug 25.

32.

Multiple changes in peptide and lipid expression associated with regeneration in the nervous system of the medicinal leech.

Meriaux C, Arafah K, Tasiemski A, Wisztorski M, Bruand J, Boidin-Wichlacz C, Desmons A, Debois D, Laprévote O, Brunelle A, Gaasterland T, Macagno E, Fournier I, Salzet M.

PLoS One. 2011 Apr 22;6(4):e18359. doi: 10.1371/journal.pone.0018359.

33.

The triterpene glycosides of Holothuria forskali: usefulness and efficiency as a chemical defense mechanism against predatory fish.

Van Dyck S, Caulier G, Todesco M, Gerbaux P, Fournier I, Wisztorski M, Flammang P.

J Exp Biol. 2011 Apr 15;214(Pt 8):1347-56. doi: 10.1242/jeb.050930.

34.

Automated querying and identification of novel peptides using MALDI mass spectrometric imaging.

Bruand J, Sistla S, Mériaux C, Dorrestein PC, Gaasterland T, Ghassemian M, Wisztorski M, Fournier I, Salzet M, Macagno E, Bafna V.

J Proteome Res. 2011 Apr 1;10(4):1915-28. doi: 10.1021/pr101159e. Epub 2011 Mar 15.

35.

Localization of secondary metabolites in marine invertebrates: contribution of MALDI MSI for the study of saponins in Cuvierian tubules of H. forskali.

Van Dyck S, Flammang P, Meriaux C, Bonnel D, Salzet M, Fournier I, Wisztorski M.

PLoS One. 2010 Nov 10;5(11):e13923. doi: 10.1371/journal.pone.0013923.

36.

MALDI imaging and profiling MS of higher mass proteins from tissue.

van Remoortere A, van Zeijl RJ, van den Oever N, Franck J, Longuespée R, Wisztorski M, Salzet M, Deelder AM, Fournier I, McDonnell LA.

J Am Soc Mass Spectrom. 2010 Nov;21(11):1922-9. doi: 10.1016/j.jasms.2010.07.011. Epub 2010 Aug 4.

37.

MALDI mass spectrometry imaging of proteins exceeding 30,000 daltons.

Franck J, Longuespée R, Wisztorski M, Van Remoortere A, Van Zeijl R, Deelder A, Salzet M, McDonnell L, Fournier I.

Med Sci Monit. 2010 Sep;16(9):BR293-9.

38.

Specific MALDI-MSI: Tag-Mass.

Stauber J, Ayed ME, Wisztorski M, Salzet M, Fournier I.

Methods Mol Biol. 2010;656:339-61. doi: 10.1007/978-1-60761-746-4_20.

PMID:
20680601
39.

On tissue protein identification improvement by N-terminal peptide derivatization.

Franck J, Ayed ME, Wisztorski M, Salzet M, Fournier I.

Methods Mol Biol. 2010;656:323-38. doi: 10.1007/978-1-60761-746-4_19.

PMID:
20680600
40.

MALDI direct analysis and imaging of frozen versus FFPE tissues: what strategy for which sample?

Wisztorski M, Franck J, Salzet M, Fournier I.

Methods Mol Biol. 2010;656:303-22. doi: 10.1007/978-1-60761-746-4_18.

PMID:
20680599
41.

Liquid ionic matrixes for MALDI mass spectrometry imaging of lipids.

Meriaux C, Franck J, Wisztorski M, Salzet M, Fournier I.

J Proteomics. 2010 Apr 18;73(6):1204-18. doi: 10.1016/j.jprot.2010.02.010. Epub 2010 Feb 24.

PMID:
20188221
42.

On-tissue protein identification and imaging by MALDI-ion mobility mass spectrometry.

Stauber J, MacAleese L, Franck J, Claude E, Snel M, Kaletas BK, Wiel IM, Wisztorski M, Fournier I, Heeren RM.

J Am Soc Mass Spectrom. 2010 Mar;21(3):338-47. doi: 10.1016/j.jasms.2009.09.016. Epub 2009 Sep 29.

43.

Polymerase chain reaction and immunoassay--matrix assisted laser desorption mass spectrometry using tag-mass technology: new tools to break down quantification limits and multiplexes.

Stauber J, El Ayed M, Wisztorski M, Day R, Fournier I, Salzet M.

Anal Chem. 2009 Nov 15;81(22):9512-21. doi: 10.1021/ac901416s.

PMID:
19839572
44.

On-tissue N-terminal peptide derivatizations for enhancing protein identification in MALDI mass spectrometric imaging strategies.

Franck J, El Ayed M, Wisztorski M, Salzet M, Fournier I.

Anal Chem. 2009 Oct 15;81(20):8305-17. doi: 10.1021/ac901043n.

PMID:
19775114
45.

Improving tissue preparation for matrix-assisted laser desorption ionization mass spectrometry imaging. Part 1: using microspotting.

Franck J, Arafah K, Barnes A, Wisztorski M, Salzet M, Fournier I.

Anal Chem. 2009 Oct 1;81(19):8193-202. doi: 10.1021/ac901328p.

PMID:
19722499
46.

MALDI imaging mass spectrometry: state of the art technology in clinical proteomics.

Franck J, Arafah K, Elayed M, Bonnel D, Vergara D, Jacquet A, Vinatier D, Wisztorski M, Day R, Fournier I, Salzet M.

Mol Cell Proteomics. 2009 Sep;8(9):2023-33. doi: 10.1074/mcp.R800016-MCP200. Epub 2009 May 18. Review.

47.

MITICS (MALDI Imaging Team Imaging Computing System): a new open source mass spectrometry imaging software.

Jardin-Mathé O, Bonnel D, Franck J, Wisztorski M, Macagno E, Fournier I, Salzet M.

J Proteomics. 2008 Aug 21;71(3):332-45. doi: 10.1016/j.jprot.2008.07.004. Epub 2008 Jul 12.

PMID:
18644473
48.

Tissue imaging using MALDI-MS: a new frontier of histopathology proteomics.

Fournier I, Wisztorski M, Salzet M.

Expert Rev Proteomics. 2008 Jun;5(3):413-24. doi: 10.1586/14789450.5.3.413. Review.

PMID:
18532909
49.

Molecular MALDI imaging: an emerging technology for neuroscience studies.

Wisztorski M, Croix D, Macagno E, Fournier I, Salzet M.

Dev Neurobiol. 2008 May;68(6):845-58. doi: 10.1002/dneu.20623. Review.

50.

MALDI imaging of formalin-fixed paraffin-embedded tissues: application to model animals of Parkinson disease for biomarker hunting.

Stauber J, Lemaire R, Franck J, Bonnel D, Croix D, Day R, Wisztorski M, Fournier I, Salzet M.

J Proteome Res. 2008 Mar;7(3):969-78. doi: 10.1021/pr070464x. Epub 2008 Feb 5.

Supplemental Content

Loading ...
Support Center